EUVIMEDEUVIMED entdecken
Crossref

Outcomes among patients with non‐ST‐elevation myocardial infarction on chronic anticoagulation: Insights from the National Inpatient Sample

Ahmed M Younes iD, Ahmed Hashem, Ahmed Maraey, Mahmoud Khalil iD, Ahmed Elzanaty iD, Islam Y Elgendy iD

Catheterization and Cardiovascular Interventions · 2024

DOI: 10.1002/ccd.31198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2024. Verfasst von Ahmed M Younes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Riverside Shore Memorial Hospital, Onancock, Virginia, USA. Hauptthemen laut MEDLINE: Non-ST Elevated Myocardial Infarction, Hospital Mortality, Anticoagulants, Hemorrhage. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic systemic anticoagulation use is prevalent for various thromboembolic conditions. Anticoagulation (usually through heparin products) is also recommended for the initial management of non‐ST‐elevation myocardial infarction (NSTEMI).

Aims

To evaluate the in‐hospital outcomes of patients with NSTEMI who have been on chronic anticoagulation.

Methods

Using the National Inpatient Sample (NIS) years 2016–2020, NSTEMI patients and patients with chronic anticoagulation were identified using the appropriate International Classification of Diseases, 10th version (ICD‐10) appropriate codes. The primary outcome was all‐cause in‐hospital mortality while the secondary outcomes included major bleeding, ischemic cerebrovascular accident (CVA), early percutaneous coronary intervention (PCI) (i.e., within 24 h of admission), coronary artery bypass graft (CABG) during hospitalization, length of stay (LOS), and total charges. Multivariate logistic or linear regression analyses were performed after adjusting for patient‐level and hospital‐level factors.

Results

Among 2,251,914 adult patients with NSTEMI, 190,540 (8.5%) were on chronic anticoagulation. Chronic anticoagulation use was associated with a lower incidence of in‐hospital mortality (adjusted odds ratio [aOR]: 0.69, 95% confidence interval [CI]: 0.65−0.73, p < 0.001). There was no significant difference in major bleeding (aOR: 0.95, 95% CI: 0.88−1.0, p = 0.15) or ischemic CVA (aOR: 0.23, 95% CI: 0.03−1.69, p = 0.15). Chronic anticoagulation use was associated with a lower incidence of early PCI (aOR: 0.78, 95% CI: 0.76−0.80, p < 0.001) and CABG (aOR: 0.43, 95% CI: 0.41−0.45, p < 0.001). Chronic anticoagulation was also associated with decreased LOS and total charges (adjusted mean difference [aMD]: −0.8 days, 95% CI: −0.86 to −0.75, p < 0.001) and (aMD: $−19,340, 95% CI: −20,692 to −17,988, p < 0.001).

Conclusions

Among patients admitted with NSTEMI, chronic anticoagulation use was associated with lower in‐hospital mortality, LOS, and total charges, with no difference in the incidence of major bleeding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-ST Elevated Myocardial InfarctionHospital MortalityAnticoagulantsHemorrhageDatabases, FactualInpatientsPercutaneous Coronary InterventionLength of StayHumansMaleFemaleUnited StatesAgedMiddle AgedTreatment OutcomeTime FactorsRisk FactorsRisk AssessmentRetrospective StudiesCoronary Artery BypassHospital CostsAged, 80 and overDrug Administration ScheduleHospital ChargesCost Savings

Stichwörter der Autor:innen

National Inpatient Sample (NIS)acute coronary syndrome (ACS)bleeding complicationschronic anticoagulationinpatient mortalitynon‐ST‐elevation myocardial infarction (NSTEMI)patient outcomesstroke

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Internal Medicine, Riverside Shore Memorial Hospital, Onancock, Virginia, USA.
  • Department of Cardiology, Ain Shams University, Cairo, Egypt.
  • Department of Cardiology, University of Toledo Medical Center, Toledo, Ohio, USA.
  • Department of Cardiology, University of Connecticut Medical Center, Farmington, Connecticut, USA.
  • Division of Cardiovascular Medicine, Gill Heart Institute, University of Kentucky, Lexington, Kentucky, USA.

ORCID-Profile: Ahmed M Younes, Mahmoud Khalil, Ahmed Elzanaty, Islam Y Elgendy

Zitieren

APA

Younes, A. M., Hashem, A., Maraey, A., Khalil, M., Elzanaty, A., & Elgendy, I. Y. (2024). Outcomes among patients with non‐ST‐elevation myocardial infarction on chronic anticoagulation: Insights from the National Inpatient Sample. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31198

Vancouver

Younes AM, Hashem A, Maraey A, Khalil M, Elzanaty A, Elgendy IY. Outcomes among patients with non‐ST‐elevation myocardial infarction on chronic anticoagulation: Insights from the National Inpatient Sample. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.31198

BibTeX
@article{Younes2024,
  author = {Younes, Ahmed M and Hashem, Ahmed and Maraey, Ahmed and Khalil, Mahmoud and Elzanaty, Ahmed and Elgendy, Islam Y},
  title = {Outcomes among patients with non‐ST‐elevation myocardial infarction on chronic anticoagulation: Insights from the National Inpatient Sample},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2024},
  doi = {10.1002/ccd.31198}
}
Kostenlos starten →